Stock Information
Ligand Pharmaceuticals Inc (LGND)
Ticker Symbol: LGND
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $4,411.78 mil
Piotroski score: 6
PE Ratio: 33.8791
EPS (TTM): 5.8832
Revenue (TTM): $12.97 M
Dividend Yield: N/A%
ROE: 13.86%
Latest News
-
Ligand Pharmaceuticals Is A Low-Risk Way To Bet On Biopharma Growth: Analyst
Wed, Mar 11, 2026 2:11 PM
-
This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
Wed, Mar 11, 2026 7:54 AM
-
B of A Securities Initiates Coverage On Ligand Pharmaceuticals with Buy Rating, Announces Price Target of $244
Wed, Mar 11, 2026 6:46 AM
Key Financials
Financial data not available
